Background and Aims: Lung cancer includes small cell lung cancer and non-small cell lung cancer (NSCLCs) types. NSCLCs are investigated for various mutations, which is available can be treated with targeted new molecular therapies. The aim of this study was to evaluate the expres...
Background: Breast cancer is the second leading cause of death in Iranian women following lung cancer with high morbidity rate among those aged 40-55 years. The aim of this study was to evaluate the expression of DKK1 and NANOG genes as prognostic biomarkers in Iranian patients w...
Background: PD-L1 is the main ligand is expressed on many tumors including lung cancer and is expressed in hematopoietic cells and various leukemia. The aim of this study was to evaluate the expression of PD-1 gene and the evaluation of cancerous grades of NSCLC and its subclasse...
Open access
Research Article10.9734/ajbgmb/2019/v2i230055
Introduction: Lung cancer is one of the biggest health problems in the world. Non-small cell lung cancers (NSCLCs), which account for approximately 85% of lung cancer cases, are the leading cause of deaths due to cancer worldwide. The type 1planned death molecule (PD-I, CD279) an...